Drug pricing in 2026 is being reshaped at the pharmacy counter, in federal agencies and in courtrooms — all at once. Within a single month, CMS finalized another round of Medicare price cuts affecting $42.5 billion in annual Part D…
Pharmacy
St. Louis-based Washington University plans to acquire the University of Health Sciences and Pharmacy and establish its own pharmacy school. Under the agreement, UHSP’s St. Louis College of Pharmacy will become WashU’s 10th academic school, according to a Feb. 24…
Osage Beach, Mo.-based Lake Regional Health System used a $2.3 million loan from the U.S. Department of Agriculture’s Rural Economic Development Loan and Grant program to complete a remodel of its inpatient pharmacy and purchase clinical equipment. The funds supported…
Becker’s asked pharmacy executives from hospitals and health systems across the U.S. to share 2026’s most pressing workforce challenges and their solutions. The 16 executives featured in this article are all speaking at the Becker’s Healthcare Spring Chief Pharmacy Officer…
A CommonSpirit hospital in Tacoma, Wash., plans to build a 16-bed infusion center in an unoccupied suite, according to permits filed with the city. The hospital, St. Joseph Medical Center, is part of Virginia Mason Franciscan Health, a member of…
Advertisement
After CVS Health surpassed its projected operating income for 2025, the company increased annual bonuses for corporate employees about 42% higher than baseline levels, Bloomberg reported Feb. 23. The bonuses for 2025 are based on net promoter score, how CVS…
The FDA has approved Bysanti (milsaperidone) tablets for the treatment of bipolar I disorder and schizophrenia in adults. The drug is indicated as a first-line therapy for acute manic or mixed episodes associated with bipolar I disorder, as well as…
Bayer has filed a lawsuit against Johnson & Johnson and Janssen Biotech, alleging the companies made false and misleading claims about the efficacy of its prostate cancer drug Nubeqa compared to the latter’s Erleada. The suit, filed in the U.S.…
In a deal worth $7.8 billion, Gilead Sciences has entered a definitive agreement to acquire Arcellx, a biotech company developing a cell therapy for multiple myeloma. Gilead announced the acquisition agreement a few months after Arcellx published positive data from…
In 2025, 85.7% of pharmacy school graduates passed the North American Pharmacist Licensure Examination on their first attempt, according to data from the National Association of Boards of Pharmacy. The NAPLEX assesses an individual’s competence to practice as a pharmacist…